Solventum Corporation/$SOLV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Solventum Corporation
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
Ticker
$SOLV
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
22,000
ISIN
US83444M1018
Website
SOLV Metrics
BasicAdvanced
$13B
33.37
$2.18
-
-
Price and volume
Market cap
$13B
52-week high
$85.92
52-week low
$47.16
Average daily volume
1.1M
Financial strength
Current ratio
1.19
Quick ratio
0.641
Long term debt to equity
239.516
Total debt to equity
242.581
Interest coverage (TTM)
2.02%
Profitability
EBITDA (TTM)
1,416
Gross margin (TTM)
54.94%
Net profit margin (TTM)
4.56%
Operating margin (TTM)
10.48%
Effective tax rate (TTM)
-20.32%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
3.84%
Return on equity (TTM)
10.66%
Valuation
Price to earnings (TTM)
33.374
Price to revenue (TTM)
1.516
Price to book
3.85
Price to tangible book (TTM)
-3.07
Price to free cash flow (TTM)
32.721
Free cash flow yield (TTM)
3.06%
Free cash flow per share (TTM)
221.97%
Growth
Revenue change (TTM)
1.29%
Earnings per share change (TTM)
-70.83%
What the Analysts think about SOLV
Analyst ratings (Buy, Hold, Sell) for Solventum Corporation stock.
Bulls say / Bears say
Solventum's sale of its Purification & Filtration business to Thermo Fisher for $4.1 billion is expected to strengthen its balance sheet by reducing debt and allowing investment in core growth areas. (reuters.com)
Activist investor Nelson Peltz's Trian Fund Management has built a significant stake in Solventum, indicating confidence in the company's potential and possibly driving strategic initiatives to enhance shareholder value. (reuters.com)
Solventum's commitment to using 100% renewable electricity by 2030 demonstrates a strong focus on sustainability, which can enhance its brand reputation and appeal to environmentally conscious investors. (prnewswire.com)
In Q2 2024, Solventum reported a 70% drop in profit due to minimal sales growth and increased expenses, raising concerns about its operational efficiency and profitability. (reuters.com)
BTIG Research initiated coverage of Solventum with a 'Neutral' rating, suggesting limited upside potential and indicating that the stock may not outperform in the near term. (marketbeat.com)
The sale of the Purification & Filtration business, while strengthening the balance sheet, reduces Solventum's revenue base and may impact its market position in the bioprocessing sector. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.
SOLV Financial Performance
Revenues and expenses
SOLV Earnings Performance
Company profitability
SOLV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Solventum Corporation stock?
Solventum Corporation (SOLV) has a market cap of $13B as of June 20, 2025.
What is the P/E ratio for Solventum Corporation stock?
The price to earnings (P/E) ratio for Solventum Corporation (SOLV) stock is 33.37 as of June 20, 2025.
Does Solventum Corporation stock pay dividends?
No, Solventum Corporation (SOLV) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Solventum Corporation dividend payment date?
Solventum Corporation (SOLV) stock does not pay dividends to its shareholders.
What is the beta indicator for Solventum Corporation?
Solventum Corporation (SOLV) does not currently have a Beta indicator.